Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.
about
Isolation of a mammalian homologue of a fission yeast differentiation regulatorA potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicityWegener autoantigen and myeloblastin are encoded by a single mRNATIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia.Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia.Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML).Differentiation therapy of leukemia: 3 decades of development.hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cellsActivation of the fructose 1,6-bisphosphatase gene by 1,25-dihydroxyvitamin D3 during monocytic differentiationAvian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells.1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.In vivo differentiation of blast-phase chronic granulocytic leukemia. Expression of c-myc and c-abl protooncogenes.Phorbol ester-induced growth arrest of murine myelomonocytic leukemic cells with virus-disrupted myb locus is not accompanied by decreased myc and myb expression.Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor alpha subunits are independently regulated in HL-60 cellsInduction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin AMultidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia.Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3).Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines.Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.Internucleosomal DNA fragmentation during phorbol ester-induced monocytic differentiation and G0/G1 arrest.Increased expression of p53 protein in human leukemia cells.Antineutrophil cytoplasm antibodies in Kawasaki disease.Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistanceUpregulation of TLR1, TLR2, TLR4, and IRAK-2 Expression During ML-1 Cell Differentiation to Macrophages: Role in the Potentiation of Cellular Responses to LPS and LTA.Morphological and isoenzymatic differentiation of B-chronic lymphocytic leukaemia cells induced by phorbolester.Establishment of the DU.528 human lymphohemopoietic stem cell lineCoding sequence and growth regulation of the human vimentin gene.Role of arachidonic acid metabolism in transcriptional induction of tumor necrosis factor gene expression by phorbol esterDissociation of c-fos induction from macrophage differentiation in human myeloid leukemic cell linesTranscriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells.Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotidesMyelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implicationsInhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.The degradation of chondrogenic pellets using cocultures of synovial fibroblasts and U937 cells.Docosahexaenoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell lineIdentification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: comparison with interleukin 1
P2860
Q22009424-ABC915AD-3FA7-4FBC-909D-A864B4CEE5FFQ22010219-F31E0343-40AE-4987-A138-788EE1279BCCQ24560307-4402C85A-3ECE-49CD-B64F-92644922AD7EQ24600120-F4E4C5B5-D6BA-4839-89B5-44641C5C979EQ30409637-832B23F1-6391-4D44-84BD-7812E5BE6EFFQ31159920-20D27A70-6838-4C4A-8413-F6C90649CC63Q33350679-84FBC3E3-1CE6-477D-9566-7E683DC7764BQ33409795-CDF89F64-5850-40D1-BC54-76E3A0825D25Q33622860-C959CC7D-532B-4069-8B06-33EB04AC269CQ33648757-E11A887C-F7CC-491D-8401-32F442BDA53AQ33795485-E6D7264B-0CC3-4280-BB56-4B0306C9250BQ33843653-3C7FC37F-41BC-477D-A740-67E1EC54DD3DQ33854728-01320F2B-8E9B-4151-B466-89BC249B4BD6Q34206010-1FDAAACC-F67D-41E7-AAC9-7634262296CEQ34544669-62A75D8F-57C7-4053-9786-74BAA5BCE36FQ34585819-A581A1F8-763D-4CFD-BF9F-B5EC99DB7ED6Q34590912-7A0560BE-8B7E-48DD-ADC3-29CBB0D60735Q34612154-3386373D-9DD7-433C-A30D-3D5E62F2D85AQ34619344-88B8F570-5175-401A-9B77-81C86CB7F12AQ34620898-D4C3BC3F-C264-46E4-939C-FE68370CBA8BQ35032944-5D92DA67-7757-4C5C-9FB6-28FED9347158Q35480200-EDCF6F1C-4166-47AE-BE6F-EA4F61BBA0E2Q35589141-2CB22734-2F59-4EBA-8D72-23BAC6892D8EQ35599479-365FE3B2-4E33-4D22-87C0-96B3B9462A19Q35609543-0317718C-DAF4-49B2-8F5E-43AC4E3D36EAQ35624317-F6CBDC2E-F4FD-49EB-B8C3-9A3095F398E0Q35954885-7FAA6D64-DB66-4E84-92BC-DA52938FF6A9Q35999689-BF986ACC-1790-47B5-93FD-1550E89AB149Q36026908-DB3A64E1-92CB-4E48-A8C5-04976A0EAD05Q36351205-097F5C76-8602-41F0-8B6C-9640B8D2D0A8Q36458716-009F6934-6299-43BC-8808-216AF951B1BBQ36753327-60D34222-5707-46BA-99AC-0C6713B87AA9Q36835206-254773A9-5626-4B82-8718-7BB66DC19E4AQ36844168-FC1EB750-7C90-473C-868F-BFE31A5D4272Q37133075-8FF88ACE-EEA2-4074-80E4-543336267301Q37195857-06A9CA45-1092-4E43-A3BF-5C5B3E48B0B9Q37212749-EEDA59D9-3B55-433D-867D-C6E88D041478Q37424417-6A528902-40CE-4A75-83F5-53F093BCBF8BQ37637146-1EA7F56F-A58C-491E-9136-7621E72452B4Q37679424-F87B22F3-F86F-416A-8A61-1AC5B94DA7DE
P2860
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Induction of differentiation o ...... lls: therapeutic implications.
@en
type
label
Induction of differentiation o ...... lls: therapeutic implications.
@en
prefLabel
Induction of differentiation o ...... lls: therapeutic implications.
@en
P1433
P1476
Induction of differentiation o ...... lls: therapeutic implications.
@en
P2093
Koeffler HP
P304
P407
P577
1983-10-01T00:00:00Z